SI-BONE, Inc. (SIBN) Investor Relations Documents

SI-BONE, Inc. (SIBN) investor relations documents from the company's IR site: 1 presentation, 10 press releases; latest deck 2026-08-03. Read in-app with summaries. First-party data.

August 2026 Investor Presentation — SI-BONE reported 15.2% worldwide revenue growth to $56.0 million in Q2 2026, driven by a record 1,715 active physicians and expanding procedural demand.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-03	Presentation	August 2026 Investor Presentation
2026-08-03	Press release	SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
2026-07-20	Press release	SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026
2026-06-04	Press release	SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
2026-05-11	Press release	SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
2026-04-30	Press release	SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026
2026-04-20	Press release	SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
2026-02-23	Press release	SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
2026-02-17	Press release	SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026
2026-02-02	Press release	SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
2026-01-12	Press release	SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

SIBN overview · SIBN earnings · SIBN financials · SIBN KPIs · SIBN ownership · SIBN peers · SIBN filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.